Seascape Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Sell |
42,619
-269
| -0.6% | -$18.8K | 0.94% | 41 |
|
|
2025
Q1 | $3.15M | Buy |
42,888
+579
| +1% | +$42.6K | 1.1% | 33 |
|
|
2024
Q4 | $2.77M | Buy |
42,309
+1,032
| +3% | +$67.6K | 0.97% | 40 |
|
|
2024
Q3 | $3.22M | Sell |
41,277
-1,506
| -4% | -$117K | 1.15% | 33 |
|
|
2024
Q2 | $3.34M | Buy |
42,783
+128
| +0.3% | +$9.98K | 1.24% | 29 |
|
|
2024
Q1 | $2.89M | Buy |
42,655
+685
| +2% | +$46.4K | 1.07% | 36 |
|
|
2023
Q4 | $2.83M | Buy |
41,970
+1,804
| +4% | +$122K | 1.19% | 32 |
|
|
2023
Q3 | $2.72M | Sell |
40,166
-93
| -0.2% | -$6.3K | 1.29% | 29 |
|
|
2023
Q2 | $2.88M | Sell |
40,259
-1,357
| -3% | -$97.1K | 1.37% | 24 |
|
|
2023
Q1 | $2.89M | Sell |
41,616
-4,567
| -10% | -$317K | 1.47% | 25 |
|
|
2022
Q4 | $3.13M | Buy |
46,183
+729
| +2% | +$49.4K | 1.71% | 17 |
|
|
2022
Q3 | $2.49M | Sell |
45,454
-290
| -0.6% | -$15.9K | 1.71% | 21 |
|
|
2022
Q2 | $3.02M | Buy |
45,744
+185
| +0.4% | +$12.2K | 1.83% | 15 |
|
|
2022
Q1 | $3.02M | Buy |
45,559
+1,407
| +3% | +$93.3K | 1.57% | 26 |
|
|
2021
Q4 | $2.57M | Buy |
44,152
+914
| +2% | +$53.2K | 1.21% | 37 |
|
|
2021
Q3 | $2.6M | Buy |
43,238
+7,254
| +20% | +$436K | 1.33% | 35 |
|
|
2021
Q2 | $2.16M | Buy |
35,984
+2,493
| +7% | +$149K | 1.12% | 39 |
|
|
2021
Q1 | $1.67M | Buy |
33,491
+4,370
| +15% | +$217K | 0.93% | 43 |
|
|
2020
Q4 | $1.46M | Sell |
29,121
-1,471
| -5% | -$73.5K | 0.85% | 44 |
|
|
2020
Q3 | $1.68M | Buy |
30,592
+868
| +3% | +$47.6K | 1.06% | 39 |
|
|
2020
Q2 | $1.57M | Buy |
+29,724
| New | +$1.57M | 1.13% | 32 |
|
|
2020
Q1 | – | Sell |
-31,899
| Closed | -$1.59M | – | 69 |
|
|
2019
Q4 | $1.59M | Buy |
+31,899
| New | +$1.59M | 1.14% | 41 |
|